IP Library › Granted Patent US 10,898,709
Granted Patent B2
US 10,898,709 · App. 15/562,714 · Granted Jan 26, 2021

Stimulation for treating sleep disordered breathing

Inventors: Darrell Wagner (Ham Lake, MN); Quan Ni (Golden Valley, MN); John Rondoni (Plymouth, MN); David Dieken (Minneapolis, MN)
Assignee: Inspire Medical Systems, Inc.
A61N1/3601A61B5/0816A61B5/0826A61B5/113A61B5/4818A61B5/4848A61B5/686A61N1/3611A61B5/0205A61N1/3614A61N1/36146A61N1/36171G06F19/3481
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,898,709
App. No.
15/562,714
Granted
Jan 26, 2021
Kind
B2
Abstract

A device for treating sleep disordered breathing includes a stimulation element to stimulate an airway-patency-related nerve.

Claims (34)

1. A device for treating obstructive sleep apnea, comprising:

a non-cardiac stimulation element to engage and to stimulate an upper-airway-patency-related nerve, according to a first stimulation therapy protocol not synchronized relative to actively-sensed respiratory information, wherein the first stimulation therapy protocol comprises a series of repeating stimulation cycles in which each stimulation cycle includes a stimulation period and a non-stimulation period,

wherein each stimulation period includes continuous stimulation and has a minimum duration equal to or greater than an inspiratory reference of a reference respiratory cycle, wherein the inspiratory reference corresponds to a duration of an inspiratory phase of the reference respiratory cycle, and wherein the reference respiratory cycle comprises at least one of:

a historical patient-specific average respiratory cycle for stable respiration; and

a multi-patient average respiratory cycle for stable respiration, and

wherein each stimulation period of each respective stimulation cycle has a duration greater than a duration of the inspiratory reference of the reference respiratory cycle and the stimulation period is followed by the non-stimulation period of the respective stimulation cycle comprising a duration less than the duration of the stimulation period.

2. The device of claim 1 , wherein the non-cardiac stimulation element comprises an implantable electrode and a pulse generator electrically connected to the implantable electrode.

3. The device of claim 2 ,

wherein the implantable electrode comprises a cuff electrode including at least one operative contact group through which the stimulation is deliverable non-selectively to the upper-airway-patency-related nerve.

4. The device of claim 1 , wherein a total duration of stimulation via the first stimulation protocol during a treatment period is greater than 30 percent of the total duration of the treatment period.

5. The device of claim 1 , wherein the duration of the stimulation period comprises

at least 50 percent of a duration of the stimulation cycle.

6. The device of claim 1 , wherein the duration of the stimulation period comprises

at least 50 percent of a duration of the reference respiratory cycle.

7. The device of claim 1 , wherein the duration of each respective stimulation cycle is less than the duration of the reference respiratory cycle, and a duration of the stimulation period exceeds the duration of the non-stimulation period by a factor of at least 3.

8. The device of claim 1 , wherein the duration of each respective stimulation cycle is greater than the duration of the reference respiratory cycle.

9. The device of claim 8 , wherein the stimulation period and the non-stimulation period are in a proportion of at least 1.5 to 1.

10. The device of claim 8 , wherein the duration of the stimulation cycle is less than a duration of two consecutive reference respiratory cycles.

11. The device of claim 1 , wherein the duration of each respective stimulation cycle is equal to the duration of the reference respiratory cycle, and wherein the duration of the reference respiratory cycle differs from a duration of a real time respiratory cycle from actively-sensed respiration information by an amount exceeding a duration variability criteria.

12. The device of claim 1 , comprising:

a processor; and

a non-volatile computer readable medium storing instructions, executable on the processor, to implement the non-cardiac stimulation element and to perform the first stimulation therapy protocol.

13. The device of claim 1 , comprising:

a sensing element to at least periodically actively sense respiratory information to obtain the actively-sensed respiratory information unrelated to stimulation synchronization,

wherein the non-cardiac stimulation element is activated for stimulation upon the sensing element identifying, via at least the actively-sensed respiratory information, obstructive sleep apnea behavior which meets or exceeds a severity threshold and wherein the non-cardiac stimulation element is deactivated upon the sensing element identifying, via at least the actively-sensed respiratory information, that the obstructive sleep apnea behavior is less than the severity threshold.

14. The device of claim 1 , comprising:

a sensing element to obtain the actively-sensed respiratory information; and

a control portion including:

a processor; and

a non-volatile memory storing instructions, executable via the processor, to:

provide convertible operation via a therapy manager between:

a first stimulation mode implementing the first stimulation therapy protocol; and

a second stimulation mode of stimulating the upper-airway-patency-related nerve synchronous with a characteristic of the actively-sensed respiratory information.

15. The device of claim 1 , wherein the stimulation period and the non-stimulation period are in a proportion of at least 1.5 to 1.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 6, 2018
From: WAGNER, DARRELL; NI, QUAN; RONDONI, JOHN; DIEKEN, DAVID
To: INSPIRE MEDICAL SYSTEMS, INC.
Reel/Frame 045122/0482 →
Continuity (2)
Provisional Application 62135305 · Mar 19, 2015
Related Publication 20180117316A1 · May 3, 2018
Cited By (8)
US 12,246,175 US 12,262,988 US 12,397,160 US 12,427,309 US 12,539,418 US 12,599,329 US 12,741,137 US 12,741,145